METHOD OF INDUCING DIFFRENTIATION OF IMMORTALIZED MESODERMAL STEM CELLS INTO NERVOUS SYSTEM CELLS

Details for Australian Patent Application No. 2002246331 (hide)

Owner RENOMEDIX INSTITUTE INC.

Inventors HONMOU, Osamu; HAMADA, Hirofumi

Pub. Number AU-A-2002246331

PCT Pub. Number WO2003/038090

Priority PCT/JP01/09510 30.10.01 JP

Filing date 3 April 2002

Wipo publication date 12 May 2003

International Classifications

C12N 015/09 Mutation or genetic engineering - Recombinant DNA-technology

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

A61K 035/12 Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 035/28 Medicinal preparations containing material or reaction products thereof with undetermined constitution - Marrow

A61P 025/00 Drugs for disorders of the nervous system

Event Publications

10 July 2003 Application Open to Public Inspection

  Published as AU-A-2002246331

15 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002246332-PROTEIN MODIFICATION-INHIBITORY COMPOSITIONS

2002246330-INSULIN-LIKE GROWTH FACTORBINDING PROTEIN